Profilo
Xiao Ping Dai is currently the Chief Technical Officer at IVERIC bio, Inc. Prior to this, she worked as the Senior Director-Biologics Development at Celgene Corp.
from 2014 to 2018, and as the Chief Technologist & VP-Technology Development at WuXi Advanced Therapies, Inc. from 2018 to 2019.
She holds a doctorate degree from the New Jersey Institute of Technology.
Posizioni attive di Xiao Ping Dai
| Società | Posizione | Inizio |
|---|---|---|
| IVERIC BIO, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Xiao Ping Dai
| Società | Posizione | Fine |
|---|---|---|
WuXi Advanced Therapies, Inc.
WuXi Advanced Therapies, Inc. BiotechnologyHealth Technology Engages in development, testing, manufacturing and commercialization of cell & gene therapies | Direttore Tecnico/Scientifico/R&S | 01/10/2019 |
| CELGENE | Corporate Officer/Principal | 01/06/2018 |
Formazione di Xiao Ping Dai
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
New Jersey Institute of Technology
New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
WuXi Advanced Therapies, Inc.
WuXi Advanced Therapies, Inc. BiotechnologyHealth Technology Engages in development, testing, manufacturing and commercialization of cell & gene therapies | Health Technology |
















